Altimmune Secures Supply Of COVID-19 Nasal Spray Vaccine

Altimmune (NASDAQ:ALT) inks an agreement with Rockville, MD-based CDMO Vigene Biosciences to manufacture its single-dose intranasal COVID-19 vaccine candidate AdCOVID.

The company is in talks with additional partners aimed at producing at least 100M doses next year.

A Phase 1 clinical trial in healthy volunteers should launch in Q4.

Shares up 3% premarket on light volume.

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.

Connect with these Baltimore Professionals on LinkedIn

  • Edwin Warfield

    Editor in Chief, Warfield Digital

    Connect
  • Jean Halle

    Independent Consultant

    Connect
  • Larry Lichtenauer

    President of Lawrence Howard & Associates

    Connect
  • Newt Fowler

    Partner at Womble Carlyle, LLP

    Connect
  • David Crowley

    Owner at Develop DC

    Connect
  • Carolyn Stinson

    Stinson Marketing Group

    Connect